Trial Profile

Phase 2, Double-blind, Randomized, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 31 Oct 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

10 Sep 2025 According to the Endo, Inc Media Release, company announced that, data from this study will be shared during the American Orthopaedic Foot & Ankle Society Annual Meeting, taking place September 10-13, 2025.
18 Oct 2024 According to an Endo Inc. media release, data from this trial will be presented during the American Society of Podiatric Surgeons (ASPS) Surgical Conference, taking place October 18-19, 2024.
18 Oct 2024 According to an Endo, Inc. media release, data from this study will be presented at the American Society of Podiatric Surgeons (ASPS) Surgical Conference, taking place October 18-19, 2024.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com